Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is 95.10% vs 140.27% in Mar 2024
Other Long Term Liabilities
YoY Growth in year ended Mar 2025 is 47.06% vs 54.55% in Mar 2024
Fixed Assets
YoY Growth in year ended Mar 2025 is 57.14% vs 21.15% in Mar 2024
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2025 is 137.26% vs 47.26% in Mar 2024
Compare Balance Sheet Results of Aptus Pharma
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
5.00
12.71
-7.71
-60.66%
Share Warrants & Outstandings
Total Reserve
1.97
204.92
-202.95
-99.04%
Shareholder's Funds
6.97
217.64
-210.67
-96.80%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
2.62
0.76
1.86
244.74%
Secured Loans
1.51
0.76
0.75
98.68%
Unsecured Loans
1.11
0.00
1.11
0.00%
Deferred Tax Assets / Liabilities
-0.07
-2.80
2.73
97.50%
Other Long Term Liabilities
0.25
0.00
0.25
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
2.20
-2.20
-100.00%
Total Non-Current Liabilities
2.80
0.16
2.64
1,650.00%
Current Liabilities
Trade Payables
1.31
41.16
-39.85
-96.82%
Other Current Liabilities
3.04
4.18
-1.14
-27.27%
Short Term Borrowings
7.74
26.45
-18.71
-70.74%
Short Term Provisions
0.00
0.79
-0.79
-100.00%
Total Current Liabilities
12.08
72.58
-60.50
-83.36%
Total Liabilities
21.85
290.38
-268.53
-92.48%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
1.86
137.77
-135.91
-98.65%
Less: Accumulated Depreciation
0.87
51.46
-50.59
-98.31%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
0.99
86.31
-85.32
-98.85%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.00
0.00
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.00
8.06
-8.06
-100.00%
Long Term Loans & Advances
0.00
1.24
-1.24
-100.00%
Other Non Current Assets
1.12
41.25
-40.13
-97.28%
Total Non-Current Assets
2.11
136.87
-134.76
-98.46%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
7.06
62.14
-55.08
-88.64%
Sundry Debtors
5.64
58.62
-52.98
-90.38%
Cash and Bank
5.21
3.58
1.63
45.53%
Other Current Assets
0.00
24.44
-24.44
-100.00%
Short Term Loans and Advances
1.82
4.73
-2.91
-61.52%
Total Current Assets
19.74
153.51
-133.77
-87.14%
Net Current Assets (Including Current Investments)
7.65
80.93
-73.28
-90.55%
Total Current Assets Excluding Current Investments
19.74
153.51
-133.77
-87.14%
Miscellaneous Expenses not written off
0.00
6.62
-6.62
-100.00%
Total Assets
21.85
290.38
-268.53
-92.48%
Contingent Liabilities
0.00
0.00
0.00
0.00%
Total Debt
10.36
27.22
-16.86
-61.94%
Book Value per share (adjusted)
13.93
171.17
-157.24
-91.86%
Annual - Borrowings
Borrowings 10.36 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 95.10% vs 140.27% in Mar 2024
Annual - Other Long Term Liabilities
Other Long Term Liabilities 0.25 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 47.06% vs 54.55% in Mar 2024
Annual - Fixed Assets
Fixed Assets 0.99 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 57.14% vs 21.15% in Mar 2024
Annual - Investments
Investments 0.00 Cr
in Mar 2025Figures in Cr
No Investments in the last few periods;
Annual - Current Assets
Current Assets 19.74 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 137.26% vs 47.26% in Mar 2024






